Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMITRIPTYLINE Cause Condition aggravated? 419 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 419 reports of Condition aggravated have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 2.1% of all adverse event reports for AMITRIPTYLINE.

419
Reports of Condition aggravated with AMITRIPTYLINE
2.1%
of all AMITRIPTYLINE reports
33
Deaths
143
Hospitalizations

How Dangerous Is Condition aggravated From AMITRIPTYLINE?

Of the 419 reports, 33 (7.9%) resulted in death, 143 (34.1%) required hospitalization, and 28 (6.7%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 419 reports have been filed with the FAERS database.

What Other Side Effects Does AMITRIPTYLINE Cause?

Toxicity to various agents (3,001) Drug ineffective (2,344) Completed suicide (1,678) Off label use (1,588) Pain (1,300) Fall (1,216) Hypotension (1,205) Drug abuse (1,116) Dizziness (1,041) Constipation (1,035)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which AMITRIPTYLINE Alternatives Have Lower Condition aggravated Risk?

AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE AMITRIPTYLINE vs AMIVANTAMAB AMITRIPTYLINE vs AMIVANTAMAB-VMJW AMITRIPTYLINE vs AMLODIPINE AMITRIPTYLINE vs AMLODIPINE BESILATE

Related Pages

AMITRIPTYLINE Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated AMITRIPTYLINE Demographics